Atea Pharmaceuticals (AVIR) revenue and earnings history
Atea Pharmaceuticals's annual figures for 8 fiscal years, as filed with the SEC.
Over 1 years, from fiscal 2020 to fiscal 2021, revenue grew at a compound rate of +622.5% a year.
Revenue and net income, 8 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | — | −$181M | −$158M | −$132M | — | — | $20.7M | $25.5M | — | $95.7M | — | 10-K |
| 2024ended Dec 31, 2024 | — |
The latest quarter, insider trades and fund moves: Atea Pharmaceuticals (AVIR) on OQRO.
Common questions
How fast has Atea Pharmaceuticals's revenue grown?
From $48.6M in fiscal 2020 to $351M in fiscal 2021: a compound annual growth rate of +622.5% over 1 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Atea Pharmaceuticals been profitable?
It reported a net loss in 7 of the years shown (2018, 2019, 2020, 2022, 2023, 2024, 2025). The highest net income was $121M in fiscal 2021.
How much cash has Atea Pharmaceuticals returned to shareholders?
Its cash-flow statements show $25.5M on buying back its own shares over 1 fiscal year ($25.5M in fiscal 2025). These are the dollar amounts paid in each year, as filed; a year with no figure means none was tagged.
Where these figures come from
The SEC’s companyfacts data: every figure Atea Pharmaceuticals tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
